TREVISAN ROBERTO

Licini, N., Trevisan, R., Lepore, G., Previdi, F., Ferramosca, A. (2026). Dynamic Target Zone Modulation for Physical Activity Management in Artificial Pancreas Using Pulsatile Zone Model Predictive Control. IEEE TRANSACTIONS ON CONTROL SYSTEMS TECHNOLOGY, 34(4 (July 2026)), 1899-1910 [10.1109/TCST.2026.3676649]. Dettaglio

Csermely, A., Borella, N., Turazzini, A., Pilati, M., Sheiban, S., Bonadonna, R., et al. (2026). Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 20(3 (May 2026)), 761-774 [10.1177/19322968241308564]. Dettaglio

Dodesini, A., Bonfadini, S., Ciriello, E., Trevisan, R. (2026). Proactive clinical programming for peripartum AID transitions. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 40(11) [10.1016/j.jdiacomp.2026.109399]. Dettaglio

Candido, R., Buzzetti, R., Consoli, A., Irace, C., Torre, E., Trevisan, R., et al. (2026). Once-weekly administration of insulin in the real-world management of type 2 diabetes. A Delphi-like consensus. ACTA DIABETOLOGICA, 63(2), 313-323 [10.1007/s00592-025-02619-8]. Dettaglio

Beernink, J., Heerspink, H., Birkenfeld, A., Cherney, D., Colhoun, H., Groop, P., et al. (2026). Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial. DIABETES CARE, 49(8), 1434-1441 [10.2337/dc26-0882]. Dettaglio